Late recurrence of pulmonic valve endocarditis in an adult patient with ventricular septal defect: a case report.
A 54-year-old female patient with a congenital ventricular septal defect (VSD) was admitted to the authors' hospital for an investigation of mild fever of four months' duration. Her history revealed pulmonary valve endocarditis contracted 18 years previously. Echocardiography revealed an echogenic mobile mass on the pulmonic valve that caused mild regurgitation, while blood cultures were positive for Streptococcus viridans. The patient was administered ceftriaxone and gentamycin, and had an uneventful clinical course. She was advised to undergo surgical closure of the VSD in order to avoid any recurrence of endocarditis.
Moyssakis
Ioannis
I
Department of Cardiology, University of Athens Medical School, Laiko General Hospital, Athens, Greece.
Kazazis
Anastasios
A
Lionakis
Nikolaos
N
Vlahodimitris
Ioannis
I
Petrikos
George
G
Votteas
Vassilios
V
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002443:Ceftriaxone / Q000627:therapeutic use; D017548:Echocardiography, Transesophageal; D004697:Endocarditis, Bacterial / Q000150:complications / Q000000981:diagnostic imaging / Q000382:microbiology*; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use; D006345:Heart Septal Defects, Ventricular / Q000150:complications*; D006801:Humans; D008875:Middle Aged; D011664:Pulmonary Valve / Q000000981:diagnostic imaging / Q000382:microbiology*; D012008:Recurrence; D013290:Streptococcal Infections / Q000175:diagnosis / Q000188:drug therapy; D034363:Viridans Streptococci / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D002443:Ceftriaxone